Method for enhancing immune cell activity in vitro (Ex Vivo: Ex vivo) for cancer immunotherapy using small molecule ablation compounds

摘要

Cancer immunotherapy in which “inducible immune anticancer agent” is induced in the host animal by intra-lesional (IL) administration of a halogenated xanthene tumor ablation compound into the solid tumor tumor of the host animal The method is disclosed. Samples of inductive immune anticancer agents are removed (collected) from the tumor-bearing host and stored as desired to form an immunologically effective concentrated tumor-specific immune anticancer agent composition. Cultured and selectively expanded. The composition is re-introduced into the host from which the predecessor inductive immune anticancer agent has been removed, or into another immunologically appropriate host in need of the composition. [Selection] Figure 1A